How much funding has Lennham Pharmaceuticals raised?

Lennham Pharmaceuticals has disclosed $3.5M raised across 2 rounds.

Where is Lennham Pharmaceuticals headquartered?

Lennham Pharmaceuticals is headquartered in Concord, US.

Lennham Pharmaceuticals

Concord, US · Founded 2019 · Delaware corporation

Find your way into Lennham Pharmaceuticals

Paths you didn't know you had: your email and LinkedIn already hold routes to the Lennham Pharmaceuticals team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lennham applies deuterium chemistry to modify the metabolic and pharmacokinetic properties of drug compounds, aiming to develop pharmaceutical products with improved profiles and patent protection. The company identifies compounds that could benefit from such modification and advances candidates with clinical and commercial potential.

Biotech Healthtech

Founders & leadership

Benjamin D. EnersonExecutive

Corey MacGregorExecutive

Bradford C. SippyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 2 rounds · 2019–2021

▶$1.2MraisedApr 2023 · 13 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Benjamin D. EnersonExecutive Officer
Bradford C. SippyExecutive Officer, Director
Corey MacGregorExecutive Officer

Offering amount: $1.2M
Amount sold: $1.2M
Minimum investment: $50K
First sale: Oct 2021
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.3MraisedMar 2021 · 19 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Corey MacGregorExecutive Officer
Benjamin D. EnersonExecutive Officer
Bradford C. SippyExecutive Officer, Director

Offering amount: $2.3M
Amount sold: $2.3M
Minimum investment: $50K
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies working in the same space as Lennham Pharmaceuticals.

Frequently asked questions

What does Lennham Pharmaceuticals do?: Lennham applies deuterium chemistry to modify the metabolic and pharmacokinetic properties of drug compounds, aiming to develop pharmaceutical products with improved profiles and patent protection. The company identifies compounds that could benefit from such modification and advances candidates with clinical and commercial potential.
How much funding has Lennham Pharmaceuticals raised?: Lennham Pharmaceuticals has disclosed $3.5M raised across 2 rounds.
Where is Lennham Pharmaceuticals headquartered?: Lennham Pharmaceuticals is headquartered in Concord, US.